CONVERSION THERAPY
Clinical trials for CONVERSION THERAPY explained in plain language.
Never miss a new study
Get alerted when new CONVERSION THERAPY trials appear
Sign up with your email to follow new studies for CONVERSION THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to turn inoperable lung cancer into a curable disease
Disease control Not yet recruitingThis study tests a new approach for people with stage III non-small cell lung cancer that cannot be removed with surgery. Participants receive a combination of an immunotherapy drug (tislelizumab), standard chemotherapy, and a targeted procedure that delivers chemotherapy directl…
Matched conditions: CONVERSION THERAPY
Phase: PHASE2 • Sponsor: Sichuan Cancer Hospital and Research Institute • Aim: Disease control
Last updated May 26, 2026 08:15 UTC
-
New tool could guide surgery decisions for tough liver cancer
Knowledge-focused Not yet recruitingThis study looks at 270 people with a type of liver cancer (intrahepatic cholangiocarcinoma) that cannot be removed right away. After initial chemotherapy, doctors will use a special evaluation system (TDTP-RECIST) to decide whether to continue medication or perform surgery. The …
Matched conditions: CONVERSION THERAPY
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC